ZELLUNA IMMUNOTHERAPY AS
816823862ActivePioneering TCR-NK cell therapies to eliminate solid cancers safely.
Yleiskatsaus
- 9
- Työntekijät
- 53t NOK
- Liikevaihto
- 2016
- Perustettu
Avainpäättäjät
Namir Hassan
Chief Executive Officer
Geir Christian Melen
Chief Financial Officer
Luise Weigand
Chief Scientific Officer
Michael Nishimura
Scientific Advisory Board Member
+15 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Zelluna is a biotechnology company dedicated to eradicating solid cancers through innovative immune therapies. Its core mission involves unleashing the immune system's power using pioneering T cell receptor (TCR) guided natural killer (NK) cell therapies, known as TCR-NK. This novel platform is desi...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Tuntematon
- Oikeudellinen muoto
- Aksjeselskap
- ALV-numero
- Tuntematon
Päättäjät
19 yhteystietoa FunnelfeedrissäNamir Hassan
Chief Executive Officer
Geir Christian Melen
Chief Financial Officer
Luise Weigand
Chief Scientific Officer
Michael Nishimura
Scientific Advisory Board Member
Emilie Gauthy
Chief Technology Officer
Anders Holm
Chief Operating Officer and Head of Business Development
May Sabry
Scientific Advisory Board Member
Omid Hamid
Scientific Advisory Board Member
Eva-Lotta Allan
Board Member
Julia Ino
Head of Project Management
Bent Jakobsen
Board Member
Charlotte Sofie Bergsagel Berg-Svendsen
Board Member
Ulrike Köhl
Scientific Advisory Board Member
Øivind Foss
Head of Clinical Operations
Dirk Jäger
Scientific Advisory Board Member
Wolf Hervé Fridman
Scientific Advisory Board Member
Hans Ivar Robinson
Board Member
Joachim Midttun
Finance Manager
Muut yhteyshenkilöt
Anders Tuv
Advisor
Samankaltaiset yritykset
20 samankaltaista yritystä Funnelfeedrissä
Ultimovacs AB
0 työntekijätPioneering off-the-shelf TCR-NK cell therapies to cure solid cancers.
CELLMOVER AS
6 työntekijätPre-clinical immunotherapy company optimizing immune cell targeting for cancer.
Symcel AB
34 työntekijätLeading provider of rapid microbial detection via biocalorimetry technology.
BIO INVENTION AS
Clinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
CuraCell TX AB
5 työntekijätEuropean biotech developing personalized T-cell therapies for solid cancer tumors.
Selaa lisää
Kysymyksiä yrityksestä ZELLUNA IMMUNOTHERAPY AS
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo